Scientific article
Open access

Prise en charge du cholangiocarcinome extrahépatique

Other titleMalignant lesions of the extrahepatic biliary system
Published inRevue médicale suisse, vol. 18, no. 786, p. 1210-1217
Publication date2022-06-15

This article provides an overview of recent advances in the diagnosis and treatment of extrahepatic cholangiocarcinomas (EH-CCAs), focusing on the role of endoscopy, surgery, and transplantation. It reviews optimal evaluation and management of patients with EH-CCA, including a careful integration of clinical information, imaging studies, cytology and/or histology, as well as a coordinated multidisciplinary approach. It reviews additional therapy such as radio-or chemotherapy either in the neoadjuvant or adjuvant setting. Furthermore, it addresses palliative approaches as well as emerging targeted therapy and immunotherapy. EH-CCAs account for nearly 90% of biliary tract malignancies and present an ongoing challenge for hepatobiliary surgeons.

  • Bile Duct Neoplasms / diagnosis
  • Bile Duct Neoplasms / pathology
  • Bile Duct Neoplasms / therapy
  • Bile Ducts, Extrahepatic / pathology
  • Bile Ducts, Intrahepatic / pathology
  • Bile Ducts, Intrahepatic / surgery
  • Cholangiocarcinoma / diagnosis
  • Cholangiocarcinoma / epidemiology
  • Cholangiocarcinoma / therapy
  • Endoscopy
  • Humans
Citation (ISO format)
LITCHINKO, Alexis et al. Prise en charge du cholangiocarcinome extrahépatique. In: Revue médicale suisse, 2022, vol. 18, n° 786, p. 1210–1217. doi: 10.53738/REVMED.2022.18.786.1210
Main files (1)
Article (Published version)
ISSN of the journal1660-9379

Technical informations

Creation06/27/2022 8:30:00 AM
First validation06/27/2022 8:30:00 AM
Update time03/16/2023 8:56:14 AM
Status update03/16/2023 8:56:14 AM
Last indexation01/17/2024 10:15:59 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack